SEC Filings
Blackstone Director Joseph Baratta To Resign December 31, And The Board Shrinks To Seven
An 8-K says Baratta will resign effective December 31, 2026, with no replacement named and the board cut from eight seats.
SEC Filings
An 8-K says Baratta will resign effective December 31, 2026, with no replacement named and the board cut from eight seats.
SEC Filings
York takes over Resource Industries on Nov. 1, while Johnson moves to an advisory role before retiring effective Feb. 1, 2027.
SEC Filings
Georgia picked Top End Mobility Group for Phase 1, about 21 miles, and for exclusive talks on the remaining phases.
SEC Filings
An 8-K shows 30-day delinquencies on U.S. consumer and small-business cards rose a tenth of a point, while net write-off rates fell.
SEC Filings
The October presentation shows a head and neck cancer study as under way and lists a first-half 2028 interim response readout.
SEC Filings
Sinda's 8-K says Barreto's exit is unrelated to any disagreement, and the board grew to nine members.
SEC Filings
Canaan's unaudited September update also shows 10 EH/s of non-JV installed hashrate and ongoing ADS buybacks funded from its crypto treasury.
SEC Filings
The board replaced David Weigand with the former Western Digital finance chief, and the offer letter adds $500,000 sign-on and guaranteed bonuses.
SEC Filings
The offering of 61,540,000 shares came with a $561 million preliminary cash estimate and a Sanofi milestone worth $10 million.
SEC Filings
The new term loan matures in 2033 but can spring earlier if $25 million or more of the 2031 convertibles remain outstanding.
SEC Filings
Marsh's 10-Q also shows commercial paper at $1.6 billion and buybacks of $2.0 billion for nine months, while the Greensill matter is closed.
SEC Filings
Full approval and patient dosing are expected within 90 days, and Ocugen cites potential revenue of $1-2M per patient.